Early research (Phase 1)Study completedNCT01905813What this trial is testingStudy of INCB040093 in Subjects With Previously Treated B-Cell MalignanciesWho this might be right forB-cell Malignancies Incyte Corporation 121
Early research (Phase 1)Study completedNCT03208959What this trial is testingA Trial of HTI-1090 in Subjects With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors Atridia Pty Ltd. 18
Early research (Phase 1)Not Yet RecruitingNCT06623279What this trial is testingOpen-laBel Dose-escalation Study for CRISPR/cas13- Rna TargetInG THerapy for the Treatment of Neovascular Age-related Macular Degeneration in Phase I TrialWho this might be right forNeovascular Age-Related Macular Degeneration (nAMD) HuidaGene Therapeutics Co., Ltd. 15
Early research (Phase 1)Study completedNCT02171143What this trial is testingA Dose Escalation Study to Assess Safety, Tolerability and Pharmacokinetics of ASP2409 Following a Single Intravenous Dose in Patients With Rheumatoid Arthritis on MethotrexateWho this might be right forRheumatoid ArthritisPharmacokinetics of ASP2409 Astellas Pharma Global Development, Inc. 58
Large-scale testing (Phase 3)Study completedNCT00326391What this trial is testingA Safety and Effectiveness Study of Methylphenidate HCl Extended-release Tablets in Adults With Attention Deficit Hyperactivity DisorderWho this might be right forAttention Deficit Disorder With Hyperactivity McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. 229
Early research (Phase 1)Study completedNCT02524678What this trial is testingPhase 1 Study(Additional) of URC102 in Healthy SubjectsWho this might be right forHealthy JW Pharmaceutical 21
Early research (Phase 1)Ended earlyNCT02106091What this trial is testingSafety Study to Assess AFM11 in Patients With Relapsed and/or Refractory CD19 Positive B-cell NHLWho this might be right forRelapsed B-Cell Non-Hodgkin LymphomaRefractory B-Cell Non-Hodgkin Lymphoma Affimed GmbH 16
Testing effectiveness (Phase 2)Study completedNCT01613118What this trial is testingRandomized, Double-Blind, Safety and Efficacy Study of RE-021 (Sparsentan) in Focal Segmental GlomerulosclerosisWho this might be right forFocal Segmental Glomerulosclerosis Travere Therapeutics, Inc. 109
Early research (Phase 1)Study completedNCT00457782What this trial is testingA Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's LymphomaWho this might be right forMultiple MyelomaChronic Lymphocytic LeukaemiaB-cell Non-Hodgkin's Lymphoma Kyowa Kirin Co., Ltd. 27
Testing effectiveness (Phase 2)Study completedNCT05069623What this trial is testingDetermine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) and VB10.2210 (T Cell Candidate) Previously Vaccinated in Healthy Adult VolunteersWho this might be right forCOVID-19Infection ViralInfections Nykode Therapeutics ASA 68
Early research (Phase 1)Study completedNCT01323985What this trial is testingSAP Depleter Dose Escalation Study in Healthy VolunteersWho this might be right forAmyloidosis GlaxoSmithKline 21
Early research (Phase 1)Looking for participantsNCT05916391What this trial is testingGene Therapy for Diabetic Macular EdemaWho this might be right forDiabetic Macular Edema Frontera Therapeutics 18
Early research (Phase 1)Study completedNCT03672695What this trial is testingPhase I Dose Escalation Study of Intravenously Administered S64315 in Combination With Orally Administered Venetoclax in Patients With Acute Myeloid Leukaemia.Who this might be right forAcute Myeloid Leukaemia Institut de Recherches Internationales Servier 37
Testing effectiveness (Phase 2)Ended earlyNCT04009681What this trial is testingA Study Evaluating Safety and Therapeutic Activity of THOR-707 in Adult Subjects With Advanced or Metastatic Solid Tumors (THOR-707-101)Who this might be right forMetastasis Synthorx, Inc, a Sanofi company 175
Early research (Phase 1)UnknownNCT04137900What this trial is testingSafety, Tolerability and Pharmacokinetics of a Monoclonal Antibody Specific to B-and T-Lymphocyte Attenuator (BTLA) as Monotherapy and in Combination With an Anti-PD1 Monoclonal Antibody for Injection in Subjects With Advanced MalignanciesWho this might be right forAdvanced Unresectable Solid TumorMetastatic Solid Tumor TopAlliance Biosciences 499
Testing effectiveness (Phase 2)UnknownNCT05465707What this trial is testingCM313 Injection in Subjects With Systemic Lupus ErythematosusWho this might be right forSystemic Lupus Erythematosus Keymed Biosciences Co.Ltd 40
Testing effectiveness (Phase 2)UnknownNCT04488107What this trial is testingSafety, Tolerability, Pharmacokinetics and Antitumor Activity of FCN-437cWho this might be right forBreast Neoplasms Ahon Pharmaceutical Co., Ltd. 78
Early research (Phase 1)Study completedNCT01944007What this trial is testingEvaluation of Cross-Linked Polyelectrolyte (CLP) in Healthy VolunteersWho this might be right forBasic Science: Safety, Tolerability, Efficacy of CLP Sorbent Therapeutics 25
Early research (Phase 1)Study completedNCT05173792What this trial is testingStudy of AK119 in Subjects With Advanced Solid TumorsWho this might be right forSolid Tumor Akeso 16
Testing effectiveness (Phase 2)Looking for participantsNCT06542237What this trial is testingOpen Label, Dose Escalation, Repeat Dose Study Evaluating YCT-529 in Healthy MalesWho this might be right forMale Contraception YourChoice Therapeutics, Inc. 88